These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1652656)

  • 1. [In vitro antifungal activity of itraconazole: a comparative study with ketoconazole].
    Hiratani T; Yamaguchi H
    Jpn J Antibiot; 1991 May; 44(5):580-7. PubMed ID: 1652656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with systemic mycoses].
    Uchida K; Matsuzaka A; Aoki K; Yamaguchi H
    Jpn J Antibiot; 1991 May; 44(5):562-70. PubMed ID: 1652654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with dermatomycoses].
    Uchida K; Hosaka J; Aoki K; Yamaguchi H
    Jpn J Antibiot; 1991 May; 44(5):571-9. PubMed ID: 1652655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antifungal activity of itraconazole and ketoconazole investigated in vitro, determined with minimal inhibitory concentrations and mycelial cell transformation in Candida albicans].
    Urbanowski S; Nierebińska E; Gwieździński Z
    Przegl Dermatol; 1989; 76(5-6):405-9. PubMed ID: 2561925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The therapeutic effects of itraconazole, a new triazole antifungal agent, for experimental fungal infections].
    Uchida K; Yamaguchi H; Shibuya K
    Jpn J Antibiot; 1991 May; 44(5):588-99. PubMed ID: 1652657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vitro susceptibility of some mycotic agents to a new orally active triazole, itraconazole.
    Otcenásek M
    J Hyg Epidemiol Microbiol Immunol; 1990; 34(2):129-34. PubMed ID: 2170505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro effect of itraconazole against various species of Candida].
    Bastide M; Mallie M; Jouvert S; Montes B; Bastide JM
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):694-9. PubMed ID: 2552381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In-vitro and in-vivo activity of itraconazole].
    Van Cutsem J
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():5-8. PubMed ID: 1663204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itraconazole activity against fungal germination.
    Strippoli V; Simonetti N; Retico A; Lucchetti G
    Drugs Exp Clin Res; 1988; 14(5):341-5. PubMed ID: 2851427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pentamidine alone and in combination with ketoconazole or itraconazole on the growth of Candida albicans.
    St-Germain G
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2304-6. PubMed ID: 1965104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro investigations of Candida strains for itraconazole].
    Gwieździński Z; Nierebińska E; Urbanowski S
    Przegl Dermatol; 1989; 76(1):23-7. PubMed ID: 2554367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in-vitro antifungal spectrum of itraconazole.
    Van Cutsem J
    Mycoses; 1989; 32 Suppl 1():7-13. PubMed ID: 2561189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro activity of fluconazole, a novel bistriazole antifungal agent].
    Yamaguchi H; Uchida K; Kawasaki K; Matsunaga T
    Jpn J Antibiot; 1989 Jan; 42(1):1-16. PubMed ID: 2540356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of itraconazole on the process of mycelial transformation of Candida albicans cells in human serum].
    Gwiezdziński Z; Urbanowski S; Nierebińska E
    Med Dosw Mikrobiol; 1989; 41(3-4):202-5. PubMed ID: 2561811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro antifungal activity of omoconazole nitrate, a new imidazole antimycotic].
    Itoyama T; Aoki Y; Hiratani T; Uchida K; Yamaguchi H
    Jpn J Antibiot; 1993 Sep; 46(9):773-80. PubMed ID: 8254897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antifungal activity of saperconazole (R 66905) against Candida and Torulopsis.
    Mallié M; Montès B; Lebecq JC; Bastide JM
    Mycoses; 1989 Dec; 32(12):631-7. PubMed ID: 2695841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of amphotericin B and intraconazole against intraphagocytic Candida albicans.
    Ponce E; Pechère JC
    Eur J Clin Microbiol Infect Dis; 1990 Oct; 9(10):738-44. PubMed ID: 2175704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of albumin on itraconazole and ketoconazole antifungal activity: results of a dynamic in vitro study.
    Schäfer-Korting M; Korting HC; Amann F; Peuser R; Lukacs A
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2053-6. PubMed ID: 1662022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative sensitivity of yeasts to ketoconazole, itraconazole and fluconazole using a liquid medium standardized micromethod].
    Guinet R; Marlier H
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):575-8. PubMed ID: 2166937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.